m+Medelevator.RU
← Поиск публикаций
Neural plasticity · 2026

The Efficacy of Individualized Music Therapy in Patients With MCS: A Pilot Study on EEG.

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhang Xiaoying, Wang Yunlei, Talifu Zuliyaer, Feng Qingqing, Gu Jiayi, Li Xiaobing, Du Xiaoxia

Аннотация

OBJECTIVE: To evaluate the feasibility, safety, and preliminary effects of individual music therapy (IMT) on electroencephalography (EEG) cortical activation in patients with minimally conscious state (MCS).

DESIGN: This study was pilot randomized, single-blind, and blank-controlled trial.

SETTING: China Rehabilitation Research Center (CRRC), Beijing, China.

PARTICIPANTS: Sixty-two MCS patients (diagnosed by Coma Recovery Scale-Revised [CRS-R]) were enrolled between March 2024 and July 2025; 43 completed the trial and were randomized.

INTERVENTION: The experimental group (n = 22) received 12-week individualized music therapy (30-min sessions, five times per week) delivered by a certified music therapist.

COMPARATOR: The control group (n = 21) received routine treatment and rehabilitation training without music intervention.

PRIMARY OUTCOME: The change in EEG spectral power (alpha band, 8-13 Hz) over right-hemisphere frontocentral regions from baseline (T1) to post-intervention (T2).

RESULTS: The IMT group showed significantly increased alpha power over the right lateral prefrontal cortex, precentral gyrus, and central sulcus at T2 compared T1 (p < 0.05; descriptive comparison), whereas no such change was observed in the control group. No adverse events occurred in either group.

CONCLUSION: IMT is feasible and safe in medically fragile MCS patients and may induce right-hemisphere cortical activation. These pilot findings are hypothesis-generating and require confirmation in larger, adequately powered trials.

TRIAL REGISTRATION: Chinese Clinical Trial Registry: ChiCTR2500114153, MR-11-24-014167.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты